We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Figure 1

Figure 1. From: [-2]proPSA for Prostate Cancer Detection: an NCI Early Detection Research Network Validation Study.

ROC analysis for all subjects (n=123) comparing PSA (AUC=0.52), %fPSA (AUC=0.61), %[-2]proPSA (AUC=0.69), and a composite logistic regression model combining PSA, BPSA, %fPSA, %[-2]proPSA, %[-2]proPSA/BPSA, and testosterone (AUC=0.73)

Lori J. Sokoll, et al. J Urol. ;180(2):539-543.
2.
Figure 2

Figure 2. From: [-2]proPSA for Prostate Cancer Detection: an NCI Early Detection Research Network Validation Study.

ROC analysis for all subjects with PSA between 2 and 10 ng/mL (n=89) comparing PSA (AUC=0.52), %fPSA (AUC=0.53), %[-2]proPSA (AUC=0.72), and a composite logistic regression model combining PSA, BPSA, %fPSA, %[-2]proPSA, [-2]proPSA/BPSA and testosterone (AUC=0.73, n=81).

Lori J. Sokoll, et al. J Urol. ;180(2):539-543.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk